GovChime
Notice ID: 531fb3f173aa429f9c7837d5ce8814e9Combined Synopsis/SolicitationArchived

AN11--Degenerative cervical myelopathy (DCM) multi-omics services

Archived on August 30, 2026. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
11:59 AM EDT
Posted
July 28, 2026
Notice type
Combined Synopsis/Solicitation
Set-aside
Total Small Business Set-Aside (FAR 19.5)
NAICS
541380: Testing Laboratories and Services
Agency
Department of Veterans Affairs

Notice details

Office
RPO EAST (36C24E)
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
36C24E26Q0072
Notice ID
531fb3f173aa429f9c7837d5ce8814e9

Description

Page 2 of 2 AMENDMENT FOR SOLICITATION 36C24E26Q0072 This solicitation is being amended to provide Question and Answers to all offerers/bidders. QUESTION and ANSWERS Q1: What sequencing depth (Gb) or number of reads per sample (M) is required for the RNA-seq component? If there is no specific target, may we recommend one? A1: 6Gb, 150 million reads Q2: What volume of plasma and whole blood will be provided per sample type? Additionally, will 40 separate samples be aliquoted for each project (i.e., dedicated plasma tubes for proteomics and for metabolomics), or will the same plasma sample be sent for both and need to be split at the facility? A2: Blood will be collected in specialized tubes (one tube is specialized for proteomics and one for metabolomics) they cannot be collected as one, and then later separated. Each subject will be given three tubes each: PAXgene blood tube will be mailed intact (zero processing), metabolomics blood sample will be centrifuged to collect plasma and placed into its dedicated Eppendorf tube and metabolomics blood sample will be centrifuged to collect plasma and placed into its dedicated Eppendorf tube. There will be 40 subjects for a total of 120 tubes (40 intact blood tubes for RNA, 40 metabolomics plasma samples, and 40 proteomics samples). Q3: The pricing table (Item 0002) specifies DIA-based LC-MS/MS proteomics, but the Scope/Task 2 narrative specifies "Olink proteomics analysis." These are different technologies (untargeted mass spec vs. targeted antibody-based panels) requiring different vendor capabilities and pricing. Please confirm which platform is required DIA-MS, Olink, or both. If Olink is required, please specify the panel (e.g., Olink Explore HT, Target 96 Inflammation, etc.). A3: Thank you for pointing out the discrepancy. DIA-base proteomics is the platform required. Extension for offers is not granted. Submission deadline remains as no later than Friday, July 31, 2026, at 11:59AM Eastern Time. IMPORTANT: complete all instructions as noted in Instructions to Offeror within original solicitation. Additionally, please complete Blocks 15A 15C AMENDMENT OF SOLICITATION document. Incomplete submissions will be considered non-responsive. All offeror quotes for this solicitation must be received electronically through email no later than Friday, July 31, 2026, at 11:59AM Eastern Time. Offers shall be sent by email to Millicent Covert at millicent.covert@va.gov. Reference solicitation number 36C24E26Q0072 within subject line of the email. Any quotes received after the prescribed date/time shall be considered non-responsive and will not be considered for award.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Ms. Millicent Covert
Contracting Officer

Documents

Files (3)

  • RFQ 36C24E26Q0072 0001_ Amendment SF30.pdf

    211 KBAdded in Combined Synopsis/Solicitation version 3Posted
    Download
  • 36C24E26Q0072_2.docx

    27 KBAdded in Combined Synopsis/Solicitation version 3Posted
    Download
  • 36C24E26Q0072_1.docx

    33 KBAdded in Combined Synopsis/Solicitation version 1Posted
    Download

Lifecycle

  1. 1
    Version 1Combined Synopsis/SolicitationArchived

    AN11--Degenerative cervical myelopathy (DCM) multi-omics services

    Notice f713e521f2394ea6b1e85c57fe0e3058 on SAM.gov

  2. 3
    Version 3Combined Synopsis/SolicitationArchivedCurrent

    AN11--Degenerative cervical myelopathy (DCM) multi-omics services

    Notice 531fb3f173aa429f9c7837d5ce8814e9 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

36C24E26Q0072

Archive Date

Aug 30, 2026

Office Address

PITTSBURGH, PA, 15212